Latest News - Xylem
Top Corporates Hub
Xylem
What You Need to Know Ahead of Xylem's Earnings Release
09.07.2026 13:02
Xylem will release its second-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth.
Xylem and Gross-Wen Technologies announce commercial partnership to advance industrial wastewater treatment solutions
25.06.2026 14:01
DES MOINES, Iowa, June 25, 2026--Gross-Wen Technologies (GWT), a provider of advanced wastewater treatment solutions, today announced a commercial partnership with Xylem, a global leader in water technology. The agreement positions GWT to accelerate expansion into the industrial wastewater sector, where tightening nutrient regulations and sustainability demands are driving adoption of integrated treatment solutions.
Xylem Inc. (NYSE:XYL): A Quality Investing Pick with Strong Fundamentals and Premium Valuation
25.06.2026 10:00
Xylem (XYL) passes a stringent quality stock screener with high ROIC, strong profit quality, and low debt, but faces a premium valuation.
Why Xylem (XYL) Fits the AI Water Strain Theme Through Reuse and Industrial Water Management
19.06.2026 08:13
Xylem Inc. (NYSE:XYL) is one of the best water infrastructure stocks to buy as AI data centers strain resources. On June 8, 2026, the company expanded its long-term partnership with Dow to design, build, and operate advanced water systems at Dow’s large-scale industrial complex in Fort Saskatchewan, Alberta. The project will support Dow’s Path2Zero operations […]
Is Xylem (XYL) Pricing Fair After Recent Share Price Weakness?
10.06.2026 04:32
Wondering whether Xylem's current share price reflects its real worth, or if the stock is mispriced in the market right now? Xylem shares last closed at US$110.87, with the stock up 0.5% over the past week but down 2.5% over 30 days, 19.1% year to date, and 12.6% over the past year. Recent coverage has focused on Xylem's position as a key player in water technology and infrastructure, along with ongoing discussion about how the company fits into long term investment themes. This context...
Everpure Jumps 34% in a Year: Should Investors Bet on the Stock?
09.06.2026 13:04
P gains 33.9% in a year, powered by surging subscriptions, high ROE, and upbeat 2027-2028 revenue and EPS estimates.
2 Industrials Stocks with Promising Prospects and 1 Facing Headwinds
03.06.2026 12:47
Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. They are also bound to benefit from a friendlier regulatory environment with the Trump administration, and this excitement has led to a six-month gain of 19.6% for the sector - higher than the S&P 500’s 10.9% return.
Here's What We Like About Xylem's (NYSE:XYL) Upcoming Dividend
23.05.2026 13:23
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
Do Wall Street Analysts Like Xylem Stock?
19.05.2026 13:40
Xylem has notably lagged the broader market over the past 52 weeks, yet Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
1 Profitable Stock to Research Further and 2 We Find Risky
19.05.2026 09:32
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Xylem Declares Second Quarter Dividend of 43 Cents per Share
18.05.2026 04:35
WASHINGTON - The Board of Directors of Xylem Inc. , has declared a second quarter dividend of $0.43 per share payable on June 25, 2026, to shareholders on record as of May 28, 2026.About XylemXylem ...
Xylem Inc. (NYSE:XYL): A Dividend Growth Anchor for Passive Income Investors
07.05.2026 09:51
Xylem Inc. (XYL) offers a reliable 1.46% dividend with 9% annual growth, strong profitability, and low debt—ideal for steady passive income investors.
2 of Wall Street’s Favorite Stocks for Long-Term Investors and 1 We Avoid
02.05.2026 18:04
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Itron: Actual Results Would Provide More Comfort Than Upbeat Words
29.04.2026 15:12
Itron's stock outlook turns cautious: muted sales, weak bookings, and acquisition risks despite upbeat guidance. Read the latest analysis on the stock here.
UBS Maintains Neutral on Xylem, Raises Price Target to $133
29.04.2026 14:53
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $132 to $133.
Citigroup Maintains Buy on Xylem, Lowers Price Target to $168
29.04.2026 13:30
Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $174 to $168.
Oppenheimer Maintains Outperform on Xylem, Lowers Price Target to $158
29.04.2026 12:58
Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $160 to $158.
Xylem: Water Business Deserves A Bigger Premium
29.04.2026 12:07
Xylem continues to eye acquisitions. Read more on what's in store for the company in 2026.
How The Xylem (XYL) Investment Story Is Shifting As Valuation And Buybacks Take Center Stage
29.04.2026 11:06
Xylem’s fair value estimate has been trimmed from US$158.41 to US$152.82, a reduction of about 3.5% that puts the current analyst debate into sharper focus. Much of this reset links back to recent Street commentary, where firms are adjusting price targets in line with revised assumptions about valuation multiples and execution risk, rather than making sweeping changes to revenue or margin outlooks. Read on to see what is driving these target moves and how you can track the evolving narrative...
Barclays Maintains Overweight on Xylem, Lowers Price Target to $154
29.04.2026 10:35
Barclays analyst William Grippin maintains Xylem (NYSE:XYL) with a Overweight and lowers the price target from $156 to $154.